154-97-2

• 常用中文名：2-吡啶肟甲磺酸甲酯
• 常用英文名：pralidoxime mesilate
• CAS号：154-97-2
• 分子式：C₈H₁₂N₂O₄S
• 分子量：232.25700
• 发布时间：2018-10-03 19:44:32
• 更新时间：2024-01-06 15:26:44

名称

• 中文名: 2-吡啶肟甲磺酸甲酯
• 英文名: pralidoxime mesylate
• 中文别名: 吡啶-2-醛肟甲基甲磺酸酯
• 英文别名: protopammethanesulfonate; pralidoximemethosulfate; 2-(hydroxyimino-methyl)-1-methyl-pyridinium,methanesulfonate; contrathion; pralidoxime mesilate; pralidoxime methanesulphonate; pralidoximemesylate; Pralidoxime methylsulfate; 2-(Hydroxyimino-methyl)-1-methyl-pyridinium,Methansulfonat; 2-PYRIDINEALDOXIME METHYL METHANESULFONATE; Pralidoxime; p2s; pyridine-2-aldoxime methyl methanesulfonate; Einecs 205-839-8; 2-pammethanesulfonate

物化性质

• 沸点: 189.7ºC at 760mmHg
• 分子式: C₈H₁₂N₂O₄S
• 分子量: 232.25700
• 闪点: 68.5ºC
• 精确质量: 232.05200
• PSA: 102.05000
• LogP: 0.56140
• 储存条件:

  2-8℃。

• 计算化学:

  1.疏水参数计算参考值（XlogP）:无

  2.氢键供体数量:1

  3.氢键受体数量:5

  4.可旋转化学键数量:1

  5.互变异构体数量:无

  6.拓扑分子极性表面积99.9

  7.重原子数量:15

  8.表面电荷:0

  9.复杂度:295

  10.同位素原子数量:0

  11.确定原子立构中心数量:0

  12.不确定原子立构中心数量:0

  13.确定化学键立构中心数量:1

  14.不确定化学键立构中心数量:0

  15.共价键单元数量:2

MSDS

Date Updated: 11/FEB/2006 Version 1.2 Regulation (EC) No 1907/2006 ________________________________________________________________________ 1 - Product and Company Information ________________________________________________________________________ Product NamePYRIDINE-2-ALDOXIME METHYL METHANESULFONATE Product NumberP0268 Company Century Ba-Shi Building 22A-B, 200020 Shanghai Technical Phone #86-21-61415566 Fax 86-21-61415567 E-mail Address ________________________________________________________________________ 2 - Hazards Identification ________________________________________________________________________ ________________________________________________________________________ 3 - Composition/Information on Ingredients ________________________________________________________________________ Product NameCAS #EC noAnnex I Index Number 2-PYRIDINEALDOXIME METHYL154-97-2 205-839-8 None METHANE-SULFONATE, 95% FormulaC7H9N2O.CH3O3S Molecular Weight 232,2600 AMU SynonymsContrathion * 2-Formyl-N-methylpyridinium oxime methanesulfonat * 2-Formyl-1-methylpyridinium methanesulfonate oxim * 2-Hydroxyiminomethyl-N-methylpyridinium methanesulphonate * N-Methylpyridinium-2-aldoxime methanesulphonate * 1-Methylpyridinium-2-aldoxime methanesulfonate * N-Methylpyridinium methane sulfonate 2-aldoxime * 2-Pam methanesulfonate * Pralidoxime mesylate * Pralidoxime methanesulfonate * Pralidoxime methosulfate * Protopam methanesulfonate * P2S * Pyridinium, 2-aldoxime, N-methyl methanesulphonat * Pyridinium, 2-((hydroxyimino)methyl)-1-methyl-, methanesulfonate (salt) (9CI) ________________________________________________________________________ 4 - First Aid Measures ________________________________________________________________________ AFTER INHALATION If inhaled, remove to fresh air. If breathing becomes difficult, call a physician. AFTER SKIN CONTACT In case of skin contact, flush with copious amounts of water for at least 15 minutes. Remove contaminated clothing and shoes. Call a physician. AFTER EYE CONTACT In case of contact with eyes, flush with copious amounts of water for at least 15 minutes. Assure adequate flushing by separating the eyelids with fingers. Call a physician. AFTER INGESTION If swallowed, wash out mouth with water provided person is conscious. Call a physician. ________________________________________________________________________ 5 - Fire Fighting Measures ________________________________________________________________________ EXTINGUISHING MEDIA Suitable: Water spray. Carbon dioxide, dry chemical powder, or appropriate foam. SPECIAL RISKS Specific Hazard(s): Emits toxic fumes under fire conditions. SPECIAL PROTECTIVE EQUIPMENT FOR FIREFIGHTERS Wear self-contained breathing apparatus and protective clothing to prevent contact with skin and eyes. ________________________________________________________________________ 6 - Accidental Release Measures ________________________________________________________________________ PROCEDURE(S) OF PERSONAL PRECAUTION(S) Wear protective equipment. METHODS FOR CLEANING UP Sweep up, place in a bag and hold for waste disposal. Avoid raising dust. Ventilate area and wash spill site after material pickup is complete. ________________________________________________________________________ 7 - Handling and Storage ________________________________________________________________________ STORAGE Store at 2-8°C ________________________________________________________________________ 8 - Exposure Controls / Personal Protection ________________________________________________________________________ ENGINEERING CONTROLS Mechanical exhaust required. PERSONAL PROTECTIVE EQUIPMENT Special Protective Measures: Wear appropriate government approved respirator, chemical-resistant gloves, safety goggles, other protective clothing. ________________________________________________________________________ 9 - Physical and Chemical Properties ________________________________________________________________________ pH N/A BP/BP RangeN/A MP/MP Range154,000. - 156,000 ° C. Flash PointN/A FlammabilityN/A Autoignition TempN/A Oxidizing Properties N/A Explosive Properties N/A Explosion LimitsN/A Vapor PressureN/A Partition Coefficient N/A ViscosityN/A Vapor DensityN/A Saturated Vapor Conc. N/A Evaporation RateN/A Bulk DensityN/A Decomposition Temp.N/A Solvent ContentN/A Water ContentN/A Surface TensionN/A ConductivityN/A Miscellaneous DataN/A SolubilityN/A ________________________________________________________________________ 10 - Stability and Reactivity ________________________________________________________________________ STABILITY Stable: Stable. HAZARDOUS DECOMPOSITION PRODUCTS Hazardous Decomposition Products: Carbon monoxide, Carbon dioxide, Nitrogen oxides, Sulfur oxides. HAZARDOUS POLYMERIZATION Hazardous Polymerization: Will not occur ________________________________________________________________________ 11 - Toxicological Information ________________________________________________________________________ RTECS NUMBER: UU4570000 ACUTE TOXICITY LD50 Oral Rat 7000,000000 mg/kg LD50 Intraperitoneal Rat 262 MG/KG Remarks: Lungs, Thorax, or Respiration:Dyspnea. Behavioral:Convulsions or effect on seizure threshold. Behavioral:Tremor. LD50 Subcutaneous Rat 332 MG/KG Remarks: Lungs, Thorax, or Respiration:Dyspnea. Behavioral:Convulsions or effect on seizure threshold. Behavioral:Tremor. LD50 Intravenous Rat 109 MG/KG Remarks: Lungs, Thorax, or Respiration:Dyspnea. Behavioral:Convulsions or effect on seizure threshold. Behavioral:Tremor. LD50 Oral Mouse 3700,000000 mg/kg LD50 Intraperitoneal Mouse 132 MG/KG LD50 Subcutaneous Mouse 165 MG/KG Remarks: Lungs, Thorax, or Respiration:Dyspnea. Behavioral:Convulsions or effect on seizure threshold. Behavioral:Tremor. LD50 Intravenous Mouse 118 MG/KG LD50 Intramuscular Monkey 356 MG/KG Remarks: Behavioral:Tremor. Behavioral:Convulsions or effect on seizure threshold. Lungs, Thorax, or Respiration:Dyspnea. LD50 Intravenous Rabbit 118 MG/KG Remarks: Behavioral:Convulsions or effect on seizure threshold. Behavioral:Muscle weakness. Lungs, Thorax, or Respiration:Cyanosis. LD50 Intramuscular Rabbit 258 MG/KG Remarks: Behavioral:Convulsions or effect on seizure threshold. Behavioral:Muscle weakness. Lungs, Thorax, or Respiration:Cyanosis. ROUTE OF EXPOSURE Multiple Routes: May cause irritation. May be harmful by inhalation, ingestion, or skin absorption. CONDITIONS AGGRAVATED BY EXPOSURE The toxicological properties have not been thoroughly investigated. ________________________________________________________________________ 12 - Ecological Information ________________________________________________________________________ No data available. ________________________________________________________________________ 13 - Disposal Considerations ________________________________________________________________________ SUBSTANCE DISPOSAL Dissolve or mix the material with a combustible solvent and burn in a chemical incinerator equipped with an afterburner and scrubber. Observe all federal, state, and local environmental regulations. ________________________________________________________________________ 14 - Transport Information ________________________________________________________________________ RID/ADR Non-hazardous for road transport. IMDG Non-hazardous for sea transport. IATA Non-hazardous for air transport. ________________________________________________________________________ 15 - Regulatory Information ________________________________________________________________________ COUNTRY SPECIFIC INFORMATION Germany WGK: 2 Self-Classification ________________________________________________________________________ 16 - Other Information ________________________________________________________________________ WARRANTY The above information is believed to be correct but does not purport to be all inclusive and shall be used only as a guide. The information in this document is based on the present state of our knowledge and is applicable to the product with regard to appropriate safety precautions. It does not represent any shall not be held liable for any damage resulting from handling or from contact with the above product. See reverse side of invoice or packing slip for additional terms and conditions of sale. unlimitedpaper copies for internal use only. DISCLAIMER For R&D use only. Not for drug, household or other uses. 模块 15 - 法规信息 N/A 模块16 - 其他信息 N/A

毒性和生态

CHEMICAL IDENTIFICATION RTECS NUMBER : UU4570000 CHEMICAL NAME : Pyridinium, 2-formyl-1-methyl-, methanesulfonate oxime CAS REGISTRY NUMBER : 154-97-2 LAST UPDATED : 199512 DATA ITEMS CITED : 14 MOLECULAR FORMULA : C7-H9-N2-O.C-H3-O3-S MOLECULAR WEIGHT : 232.28 WISWESSER LINE NOTATION : T6KJ A1 B1UNQ &Q &OSW1 HEALTH HAZARD DATA ACUTE TOXICITY DATA TYPE OF TEST : TDLo - Lowest published toxic dose ROUTE OF EXPOSURE : Oral SPECIES OBSERVED : Human DOSE/DURATION : 52500 mg/kg/4W-I TOXIC EFFECTS : Gastrointestinal - other changes REFERENCE : AEHLAU Archives of Environmental Health. (Heldref Pub., 4000 Albemarle St., NW, Washington, DC 20016) V.1- 1960- Volume(issue)/page/year: 15,599,1967 TYPE OF TEST : TDLo - Lowest published toxic dose ROUTE OF EXPOSURE : Intravenous SPECIES OBSERVED : Human DOSE/DURATION : 45 mg/kg TOXIC EFFECTS : Vascular - BP elevation not characterized in autonomic section REFERENCE : AEHLAU Archives of Environmental Health. (Heldref Pub., 4000 Albemarle St., NW, Washington, DC 20016) V.1- 1960- Volume(issue)/page/year: 15,599,1967 TYPE OF TEST : LD50 - Lethal dose, 50 percent kill ROUTE OF EXPOSURE : Oral SPECIES OBSERVED : Rodent - rat DOSE/DURATION : 7 gm/kg TOXIC EFFECTS : Details of toxic effects not reported other than lethal dose value REFERENCE : CJBPAZ Canadian Journal of Biochemistry and Physiology. (Ottawa, Ont., Canada) V.32-41, 1954-63. For publisher information, see CJBIAE. Volume(issue)/page/year: 39,351,1961 TYPE OF TEST : LD50 - Lethal dose, 50 percent kill ROUTE OF EXPOSURE : Intraperitoneal SPECIES OBSERVED : Rodent - rat DOSE/DURATION : 262 mg/kg TOXIC EFFECTS : Behavioral - tremor Behavioral - convulsions or effect on seizure threshold Lungs, Thorax, or Respiration - dyspnea REFERENCE : BJPCAL British Journal of Pharmacology and Chemotherapy. (London, UK) V.1-33, 1946-68. For publisher information, see BJPCBM. Volume(issue)/page/year: 13,202,1958 TYPE OF TEST : LD50 - Lethal dose, 50 percent kill ROUTE OF EXPOSURE : Subcutaneous SPECIES OBSERVED : Rodent - rat DOSE/DURATION : 332 mg/kg TOXIC EFFECTS : Behavioral - tremor Behavioral - convulsions or effect on seizure threshold Lungs, Thorax, or Respiration - dyspnea REFERENCE : BJPCAL British Journal of Pharmacology and Chemotherapy. (London, UK) V.1-33, 1946-68. For publisher information, see BJPCBM. Volume(issue)/page/year: 13,202,1958 TYPE OF TEST : LD50 - Lethal dose, 50 percent kill ROUTE OF EXPOSURE : Intravenous SPECIES OBSERVED : Rodent - rat DOSE/DURATION : 109 mg/kg TOXIC EFFECTS : Behavioral - tremor Behavioral - convulsions or effect on seizure threshold Lungs, Thorax, or Respiration - dyspnea REFERENCE : BJPCAL British Journal of Pharmacology and Chemotherapy. (London, UK) V.1-33, 1946-68. For publisher information, see BJPCBM. Volume(issue)/page/year: 13,202,1958 TYPE OF TEST : LD50 - Lethal dose, 50 percent kill ROUTE OF EXPOSURE : Oral SPECIES OBSERVED : Rodent - mouse DOSE/DURATION : 3700 mg/kg TOXIC EFFECTS : Details of toxic effects not reported other than lethal dose value REFERENCE : CJBPAZ Canadian Journal of Biochemistry and Physiology. (Ottawa, Ont., Canada) V.32-41, 1954-63. For publisher information, see CJBIAE. Volume(issue)/page/year: 39,351,1961 TYPE OF TEST : LD50 - Lethal dose, 50 percent kill ROUTE OF EXPOSURE : Intraperitoneal SPECIES OBSERVED : Rodent - mouse DOSE/DURATION : 132 mg/kg TOXIC EFFECTS : Details of toxic effects not reported other than lethal dose value REFERENCE : BCPCA6 Biochemical Pharmacology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1958- Volume(issue)/page/year: 7,232,1961 TYPE OF TEST : LD50 - Lethal dose, 50 percent kill ROUTE OF EXPOSURE : Subcutaneous SPECIES OBSERVED : Rodent - mouse DOSE/DURATION : 165 mg/kg TOXIC EFFECTS : Behavioral - tremor Behavioral - convulsions or effect on seizure threshold Lungs, Thorax, or Respiration - dyspnea REFERENCE : BJPCAL British Journal of Pharmacology and Chemotherapy. (London, UK) V.1-33, 1946-68. For publisher information, see BJPCBM. Volume(issue)/page/year: 13,202,1958 TYPE OF TEST : LD50 - Lethal dose, 50 percent kill ROUTE OF EXPOSURE : Intravenous SPECIES OBSERVED : Rodent - mouse DOSE/DURATION : 118 mg/kg TOXIC EFFECTS : Details of toxic effects not reported other than lethal dose value REFERENCE : JPETAB Journal of Pharmacology and Experimental Therapeutics. (Williams & Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- Volume(issue)/page/year: 132,50,1961 TYPE OF TEST : LD50 - Lethal dose, 50 percent kill ROUTE OF EXPOSURE : Intramuscular SPECIES OBSERVED : Primate - monkey DOSE/DURATION : 356 mg/kg TOXIC EFFECTS : Behavioral - tremor Behavioral - convulsions or effect on seizure threshold Lungs, Thorax, or Respiration - dyspnea REFERENCE : BJPCAL British Journal of Pharmacology and Chemotherapy. (London, UK) V.1-33, 1946-68. For publisher information, see BJPCBM. Volume(issue)/page/year: 13,202,1958 TYPE OF TEST : LD50 - Lethal dose, 50 percent kill ROUTE OF EXPOSURE : Intravenous SPECIES OBSERVED : Rodent - rabbit DOSE/DURATION : 118 mg/kg TOXIC EFFECTS : Behavioral - convulsions or effect on seizure threshold Behavioral - muscle weakness Lungs, Thorax, or Respiration - cyanosis REFERENCE : TXAPA9 Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- Volume(issue)/page/year: 33,559,1975 TYPE OF TEST : LD50 - Lethal dose, 50 percent kill ROUTE OF EXPOSURE : Intramuscular SPECIES OBSERVED : Rodent - rabbit DOSE/DURATION : 258 mg/kg TOXIC EFFECTS : Behavioral - convulsions or effect on seizure threshold Behavioral - muscle weakness Lungs, Thorax, or Respiration - cyanosis REFERENCE : TXAPA9 Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- Volume(issue)/page/year: 33,559,1975 *** REVIEWS *** TOXICOLOGY REVIEW JPMSAE Journal of Pharmaceutical Sciences. (American Pharmaceutical Assoc., 2215 Constitution Ave., NW, Washington, DC 20037) V.50- 1961- Volume(issue)/page/year: 53,1143,1964

合成路线

873-69-8 66-27-3 ~88% 154-97-2

文献：Unnisa, Lateef; Sumakanth; Rao, B. Leelamaheswara; Divi, Murali Krishnaprasad; Rao, Mysore Aswathanarayana Indian Journal of Chemistry - Section B Organic and Medicinal Chemistry, 2014 , vol. 53, # 4 p. 431 - 435

66-27-3 1193-96-0 ~% 154-97-2

文献：Journal of Pharmacy and Pharmacology, , vol. 11, p. 485 Biochemical Journal, , vol. 72, p. 70

上下游产品

上游产品  3
873-69-8 66-27-3 1193-96-0
下游产品  1
51-15-0